Tambacounda Health District
Welcome,         Profile    Billing    Logout  
 1 Trial 
7 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hsiang, Michelle S
FLAME, NCT05690841: FocaL Mass Drug Administration for Vivax Malaria Elimination

Recruiting
3
7530
RoW
Focal Mass Drug Administration (fMDA)
University of California, San Francisco, Universidad Peruana Cayetano Heredia- subcontractor to UCSF as local Sponsor, PATH, Stanford University, Eijkman Oxford Clinical Research Unit, Indonesia, Menzies School of Health Research, National Institute of Allergy and Infectious Diseases (NIAID)
Malaria, Vivax, Malaria
05/27
05/27
NCT04864444: Mass Drug Administration of Dihydroartemisinin-piperaquine + Single Low-dose Primaquine to Accelerate Toward Elimination Activities

Completed
N/A
10715
RoW
Dihydroartemisinin-piperaquine, Duo-Cotecxin, Primaquine
University of California, San Francisco, L'université de Thiès, Programme National de Lutte contre le Paludisme (PNLP), Senegal, Population Services International, Centers for Disease Control and Prevention, US President's Malaria Initiative
Malaria,Falciparum, Malaria
12/22
06/23
CHILD Malaria, NCT05567016: CHILD (Child Health and Infection With Low Density) Malaria

Active, not recruiting
N/A
600
RoW
Active case detection using molecular testing (ACDm), Passive case detection using molecular testing (PCDm), Control (standard of care)
University of California, San Francisco, National Institute of Allergy and Infectious Diseases (NIAID), Ifakara Health Institute, Swiss Tropical & Public Health Institute, Stanford University, Chan Zuckerberg Biohub
Malaria,Falciparum, Malaria
11/25
11/25
Ndiaye, Jean Louis
NCT06225297: Evaluation of Vector and Chemoprevention-based Interventions to Reduce Malaria Burden in Urban Daaras of Touba, Senegal

Active, not recruiting
4
4600
RoW
Intervention package
PATH, L'université de Thiès, University of California, San Francisco, Tulane University
Malaria
12/24
01/25
NCT04864444: Mass Drug Administration of Dihydroartemisinin-piperaquine + Single Low-dose Primaquine to Accelerate Toward Elimination Activities

Completed
N/A
10715
RoW
Dihydroartemisinin-piperaquine, Duo-Cotecxin, Primaquine
University of California, San Francisco, L'université de Thiès, Programme National de Lutte contre le Paludisme (PNLP), Senegal, Population Services International, Centers for Disease Control and Prevention, US President's Malaria Initiative
Malaria,Falciparum, Malaria
12/22
06/23
Séne, Doudou
NCT04864444: Mass Drug Administration of Dihydroartemisinin-piperaquine + Single Low-dose Primaquine to Accelerate Toward Elimination Activities

Completed
N/A
10715
RoW
Dihydroartemisinin-piperaquine, Duo-Cotecxin, Primaquine
University of California, San Francisco, L'université de Thiès, Programme National de Lutte contre le Paludisme (PNLP), Senegal, Population Services International, Centers for Disease Control and Prevention, US President's Malaria Initiative
Malaria,Falciparum, Malaria
12/22
06/23
Sturm-Ramirez, Katharine
NCT04864444: Mass Drug Administration of Dihydroartemisinin-piperaquine + Single Low-dose Primaquine to Accelerate Toward Elimination Activities

Completed
N/A
10715
RoW
Dihydroartemisinin-piperaquine, Duo-Cotecxin, Primaquine
University of California, San Francisco, L'université de Thiès, Programme National de Lutte contre le Paludisme (PNLP), Senegal, Population Services International, Centers for Disease Control and Prevention, US President's Malaria Initiative
Malaria,Falciparum, Malaria
12/22
06/23
Ba, El-hadji
No trials found

Download Options